WAKU reports ¥480m pre-Series A total after August equity and lending
The latest ¥300m comprises ¥150m equity and ¥150m loans, following a ¥180m equity raise in July 2025.
WAKU completed ¥150 million in equity financing and ¥150 million in loans in August 2026. Together with a ¥180 million equity raise in July 2025, the pre-Series A financing totals ¥480 million.
The company plans to scale sales, manufacturing, distribution and overseas business for its commercial WAKUFUL crop biostimulant. It will also advance fission-yeast research and production of high-function materials.
WAKUFUL uses glutathione to support crop responses to heat, drought and other environmental stress. The financing spans expansion of that existing product and development of a separate biomanufacturing platform.
Use of funds
Scale WAKUFUL sales, manufacturing, distribution and overseas business
Advance fission-yeast R&D and high-function material production